# A Single-arm, Multicenter, Exploratory Study of Adebrelimab Combined With Apatinib and Systemic Chemotherapy for Initially Unresectable Biliary Tract Cancer

> **NCT07135544** · PHASE2 · RECRUITING · sponsor: **Yongjun Chen** · enrollment: 37 (estimated)

## Conditions studied

- Biliary Tract Cancer
- Biliary Tract Cancer (CCA)

## Interventions

- **DRUG:** Adebrelimab combined with the GC regimen and Apatinib

## Key facts

- **NCT ID:** NCT07135544
- **Lead sponsor:** Yongjun Chen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-14
- **Primary completion:** 2027-06-30
- **Final completion:** 2028-12-30
- **Target enrollment:** 37 (ESTIMATED)
- **Last updated:** 2025-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07135544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07135544, "A Single-arm, Multicenter, Exploratory Study of Adebrelimab Combined With Apatinib and Systemic Chemotherapy for Initially Unresectable Biliary Tract Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07135544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*